Richard Mulligan is Director of BIOGEN INC.. Currently has a direct ownership of 15,099 shares of BIIB, which is worth approximately $2.4 Million. The most recent transaction as insider was on Jun 15, 2022, when has been sold 1,370 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K
0% 3M change
0% 12M change
Total Value Held $2.4 Million

Richard Mulligan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2022
BUY
Grant, award, or other acquisition
-
1,370 Added 8.32%
15,099 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
775 Added 5.34%
13,729 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
BHC
Bausch Health Companies Inc. Healthcare
RM

Richard Mulligan

Director
Bridgewater, NJ

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Track Activities on BIIB